15 March 2019
Free expert webcast on latest therapies and ideas in obesity treatment
HealthEd’s obesity hot topics free webcast is this coming Monday at 7.30pm AEDT and will feature experts reviewing the latest ideas in neurohormonal mechanisms of obesity, clinical applications pharmacotherapy and a review of the data for the new obesity drug Contrave.
Neurohormonal Mechanisms of Obesity
Prof Michael Cowley, Physiologist; Professor and Head of Department of Physiology, Monash University.
How the brain plays a pivotal role in weight regulation and the hypothalamic hunger system and the mesolimbic reward system are key centres controlling food intake. A look at how naltrexone and bupropion exert effects on both the hypothalamic hunger system and mesolimbic reward system, resulting in in altered eating behaviour and weight loss
The Clinical Development Program for Naltrexone and Bupropion Combination
Dr Scott Kahan, Physician; Director, National Center for Weight and Wellness; Faculties of John Hopkins Bloomberg School of Public Health and George Washington University School of Public Health and Health Services.
The efficacy and safety data for the naltrexone bupropion combination recently approved for weight management in Australia.
Clinical Applications for the use of Pharmacotherapy in Australian General Practice
Prof John Dixon, Professorial Research Fellow, Baker Heart and Diabetes Institute.
Practical advice on the quality use of medicines for the treatment of obesity, including patient selection criteria.
State by state times are as follows:
7:00pm – 8:30pm (NSW, VIC, TAS, ACT)
6:00pm – 7:30pm (QLD)
6:30pm – 8:00pm (SA)
5:30pm – 7:00pm (NT)
4:00pm – 5:30pm (WA)
NOTE: This event is for healthcare professionals only.